Even though the common Markov structure used in existing HTA submissions for AS treatments incorporates most aspects of disease progression, areas for improvement were identified. The proposed model matches clinical practice and improves decision making for biologic treatments.
A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING ANKYLOSING SPONDYLITIS TREATMENTS [MEETING ABSTRACT PMS52]
Graham, C., Gunda, P., Miles, L., Jugl, SM., Palaka, E., & McBride, D. (2016). A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING ANKYLOSING SPONDYLITIS TREATMENTS [MEETING ABSTRACT PMS52]. Value in Health, 19(3), A234-A234. https://doi.org/10.1016/j.jval.2016.03.1152
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.